to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Lingen, Mark W.
One or more keywords matched the following items that are connected to
Lingen, Mark W.
Understanding the biology of oral cancer and chemoprevention.
Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Critical evaluation of diagnostic aids for the detection of oral cancer.
ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis.
Assuring dental student head and neck cancer screening competency.
Genetics/epigenetics of oral premalignancy: current status and future research.
Validation of LOH profiles for assessing oral cancer risk.
Can saliva-based HPV tests establish cancer risk and guide patient management?
Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.
Oral cancer screening aids: where is the science?
Screening for oral premalignancy and cancer: what platform and which biomarkers?
CD34 and a smooth muscle actin distinguish verrucous hyperplasia from verrucous carcinoma.
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.